Post by
Ellesse on Jun 07, 2016 8:37am
Goldman Sachs : C$42 target
CXR.TO : starts with neutral rating and C$42 target
Comment by
marcrobert on Jun 07, 2016 9:29am
That's good news! Means they are interested, probably in banking fees related to the sale. Will put the name on more radar screens, although some will want to wait a year to see how healthcare shakes out after the election.
Comment by
DrugPusher on Jun 07, 2016 9:36am
This post has been removed in accordance with Community Policy
Comment by
select1011 on Jun 07, 2016 10:07am
This post has been removed in accordance with Community Policy
Comment by
OscarTheGrouch on Jun 07, 2016 10:24am
This post has been removed in accordance with Community Policy